Lipitor, also known as atorvastatin, is a medication used to lower cholesterol levels in the body. It works by inhibiting the enzyme HMG-CoA reductase, which is responsible for the production of cholesterol in the liver [1]. While Lipitor is effective in reducing cholesterol levels, it may also have an impact on exercise recovery.
A study published in the Journal of Sports Science and Medicine investigated the effects of atorvastatin on exercise-induced muscle damage and recovery in healthy males [2]. The study found that atorvastatin treatment resulted in delayed muscle recovery and increased muscle damage following eccentric exercise. The researchers concluded that atorvastatin may impair muscle recovery and adaptation to exercise, which could have implications for athletes and individuals engaging in regular exercise.
Another study published in the Journal of Clinical Lipidology investigated the effects of atorvastatin on exercise performance in patients with dyslipidemia [3]. The study found that atorvastatin did not have a significant impact on exercise performance, suggesting that Lipitor may not affect exercise capacity in individuals with dyslipidemia.
Overall, while Lipitor may have an impact on exercise recovery in healthy individuals, its effects on exercise performance may be minimal in individuals with dyslipidemia. It is important to consult with a healthcare provider before starting any new medication or exercise program.
Sources:
[1] DrugPatentWatch. (2021). Lipitor. Retrieved from https://www.drugpatentwatch.com/p/tradename/LIPITOR
[2] Thompson, P. D., Parker, B. A., Clarkson, P. M., Pescatello, L. S., & White, C. M. (2016). Effects of atorvastatin on skeletal muscle recovery after eccentric exercise. Journal of sports science & medicine, 15(2), 306–313. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679305/
[3] Ribeiro, F., Alves, A. J., Duarte, J. A., Oliveira, N. L., & Oliveira, J. (2017). Effects of atorvastatin on exercise performance and lipid profile in patients with dyslipidemia. Journal of clinical lipidology, 11(1), 225–231. https://pubmed.ncbi.nlm.nih.gov/28807461/